Volume 67, Issue 6 pp. 464-468
CLINICAL RESEARCH ARTICLE

Incidence and causes of overdiagnosis of myasthenia gravis

Nirmal Andrapalliyal MD

Nirmal Andrapalliyal MD

Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Contribution: Conceptualization, Data curation, Formal analysis, Writing - original draft, Writing - review & editing

Search for more papers by this author
Benjamin Claytor MD

Benjamin Claytor MD

Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Contribution: Formal analysis, ​Investigation, Writing - original draft, Writing - review & editing

Search for more papers by this author
Yuebing Li MD, PhD

Corresponding Author

Yuebing Li MD, PhD

Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Correspondence

Yuebing Li, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Email: [email protected]

Contribution: Conceptualization, Data curation, Formal analysis, Project administration, Supervision, Writing - original draft, Writing - review & editing

Search for more papers by this author
First published: 19 December 2022
Citations: 3

Abstract

Introduction/Aims

We have encountered non-myasthenic patients being given a diagnosis of myasthenia gravis (MG). This study aims to investigate the frequency of, and factors contributing to, overdiagnosis of MG.

Methods

This is a retrospective analysis of patients referred to our tertiary neuromuscular center for evaluation due to a previously suspected/confirmed MG diagnosis during a 6-year span.

Results

A total of 531 patients sought a second opinion regarding their MG diagnosis, and 77 (14.5%) were found to have non-myasthenic conditions. A total of 11 patients tested positive for acetylcholine receptor (AChR) antibodies. Repeated AChR antibodies became negative in five patients while in four patients, AChR binding antibody titers were persistently low. In seven patients, striational antibody was the only positive antibody identified. In 25 patients, a prior electrodiagnostic (EDX) study was deemed positive, including 14 patients with abnormal repetitive nerve stimulation (RNS) and 12 with abnormal single fiber electromyography (SFEMG). Technical issues were noted on prior RNS studies in 8 patients, and repeat RNS was negative in 10 patients. In eight patients with previously abnormal SFEMG, results showed minimal or equivocal abnormalities. In two patients, a repeat SFEMG was normal. Further analysis revealed atypical clinical presentation, deceptively positive ice pack test, clinically insignificant antibody result and misleading EDX finding as main contributors to MG overdiagnosis.

Discussion

Overdiagnosis of MG is not uncommon, and occurs more frequently in seronegative patients. To make an accurate diagnosis of MG, there is a need to recognize atypical presentations, and avoid overreliance on minor or non-specific serological and electrodiagnostic findings.

Abstract

See Editorial on pages 436–438 in this issue.

CONFLICT OF INTEREST

Dr. Yuebing Li has consulted for Argenx, Catalyst, Immunovant, and UCB Pharma and has received grant support from Argenx.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me